• 1. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 2. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 3. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 4. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 5. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608

Chemical Profile of 5-bromo-2,4-dimethoxy-3-methylbenzaldehyde (CAS No. 28006-93-1)

5-bromo-2,4-dimethoxy-3-methylbenzaldehyde, identified by its CAS number 28006-93-1, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and synthetic biology. This aromatic aldehyde features a unique structural motif comprising a benzene ring substituted with bromine, methoxy, and methyl groups, along with an aldehyde functional group at the third position. The combination of these substituents imparts distinct electronic and steric properties, making it a valuable intermediate in the synthesis of various biologically active molecules.

The compound's structural framework positions it as a versatile precursor in medicinal chemistry, particularly in the development of novel therapeutic agents. Its aromatic system allows for facile functionalization through cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are pivotal in constructing complex heterocyclic scaffolds. These transformations have been extensively explored in recent years for the generation of small-molecule inhibitors targeting intricate biological pathways.

In recent years, 5-bromo-2,4-dimethoxy-3-methylbenzaldehyde has been utilized in the synthesis of several pharmacologically relevant compounds. For instance, researchers have leveraged its aldehyde functionality to form Schiff bases, which exhibit diverse biological activities including anti-inflammatory, antimicrobial, and antioxidant properties. The presence of the bromine atom further enhances its reactivity, enabling halogen-metal exchange reactions that facilitate the introduction of other functional groups. Such modifications have been instrumental in designing molecules with improved pharmacokinetic profiles.

One notable application of this compound lies in its role as a key intermediate in the development of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways and are implicated in numerous diseases, including cancer. By modifying the 5-bromo-2,4-dimethoxy-3-methylbenzaldehyde scaffold, chemists have synthesized derivatives that selectively inhibit specific kinases without affecting others. These inhibitors have shown promise in preclinical studies and are being further optimized for clinical translation.

The methoxy and methyl groups on the benzene ring contribute to the compound's lipophilicity and metabolic stability, which are critical factors in drug design. Additionally, the bromine substituent can serve as a handle for further derivatization via transition-metal-catalyzed reactions, allowing for the construction of more complex molecular architectures. This flexibility has made 5-bromo-2,4-dimethoxy-3-methylbenzaldehyde a preferred building block for medicinal chemists seeking to develop next-generation therapeutics.

Recent advances in computational chemistry have also highlighted the potential of 5-bromo-2,4-dimethoxy-3-methylbenzaldehyde as a scaffold for drug discovery. Molecular docking studies have demonstrated its ability to interact with target proteins through hydrophobic and hydrogen bonding interactions. These insights have guided the rational design of analogs with enhanced binding affinity and selectivity. Furthermore, virtual screening techniques have been employed to identify novel derivatives with improved pharmacological properties.

The compound's utility extends beyond academia and pharmaceutical research. In industrial applications, 5-bromo-2,4-dimethoxy-3-methylbenzaldehyde serves as a precursor for fine chemicals and specialty materials. Its aromatic structure and functional groups make it suitable for synthesizing dyes, fragrances, and polymers. The growing demand for high-performance materials has spurred interest in developing efficient synthetic routes to this intermediate.

In conclusion,5-bromo-2,4-dimethoxy-3-methylbenzaldehyde (CAS No. 28006-93-1) is a multifaceted compound with significant potential in pharmaceutical research and industrial applications. Its unique structural features enable diverse chemical transformations, making it an indispensable tool for synthetic chemists. As research continues to uncover new biological activities and synthetic methodologies,5-bromo-2,4-dimethoxy-3-methylbenzaldehyde is poised to remain at the forefront of chemical innovation.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)